Thyroid drug recall affects multiple dosage strengths across U.S.

Major Pharmaceuticals has initiated a voluntary nationwide recall for several lots of levothyroxine sodium tablets. This medication is commonly prescribed to treat hypothyroidism. The company issued the recall due to concerns that these tablets are subpotent. This means the medication may contain a lower concentration of the active ingredient than the label indicates.

The recall encompasses twelve separate product lines across seven different dosage strengths. Affected products range from 25 mcg to 150 mcg. These tablets were packaged and distributed from Indianapolis. If you take this medication, check your bottle immediately to see if your prescription is part of this recall. You can find the lot number on your medication packaging.

Subpotent thyroid medication presents a health risk because patients may not receive the full dosage required to manage their condition. This can lead to the return or worsening of hypothyroid symptoms like persistent fatigue, weight gain, cold sensitivity, and cognitive challenges. The FDA has classified this as a Class II recall. This category indicates that the medication could cause temporary or medically reversible adverse health consequences.

If your medication is affected, do not simply stop taking it. Contact your physician or pharmacist to discuss next steps and receive a safe replacement. Healthcare providers and pharmacies currently holding these lots should quarantine their inventory immediately to prevent further distribution.